NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NuvoBio

NuvoBio

Private
Ottawa, OntarioHealthcare & Life Scienceshttps://nuvobio.com/

Last Round

Accelerator

Mar 13, 2026

Total Funding Raised

$173,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NuvoBio is a drug discovery company that develops a bio-medical technology platform designed to expedite the development of peptide therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoverypeptide therapeuticsdrug discovery platformgenerative biologyin silico drug discoveryAI biotechpeptide designdrug discovery partnershipsbiotechnologycancer therapeuticsinfectious disease treatmentcomputational modelingproprietary drug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NuvoBio Comparables

Compare NuvoBio with similar companies based on industry and business-model similarity.

NuvoBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

NuvoBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 13, 2026
GrantDec 3, 2024
AcceleratorMay 1, 2024

Key People

Founding team and executive leadership

Valentina Lukinović

Co-founder Chief Operating Officer

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    $100K raised, led by Merck Digital Sciences Studio.

  • Dec 3, 2024

    $73K grant round led by Capital BioVentures.

NuvoBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NuvoBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NuvoBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersOttawa, Ontario
Employee Range6
Year Founded2016
Last FundingMar 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.